Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.

Herpes simplex virus type 1 (HSV-1) thymidine kinase is currently used as a suicide agent in the gene therapy of cancer. This therapy is based on the preferential phosphorylation of nucleoside analogs by tumor cells expressing HSV-1 thymidine kinase. However, the use of HSV-1 thymidine kinase is lim...

Full description

Saved in:
Bibliographic Details
Main Authors: Black, M E, Newcomb, T G, Wilson, H M, Loeb, L A
Format: Artigo
Language:Inglês
Published: 1996
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC39643/
https://ncbi.nlm.nih.gov/pubmed/8622970
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items